Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: Atypical glandular cells (AGC) in cervical cytology are often ignored, and the malignancy risk associated with AGC remains uncertain. This study aims to evaluate the histopathology and clinical correlations in patients diagnosed with AGC through cervical cytology.
Methods: This study was retrospectively analyzed 402 patients who diagnosed with AGC using cervical cytology in our hospital between March 2017 and June 2024. Among these, high-risk human papillomavirus (hrHPV) results and histopathological findings within 1-year follow-up were included.
Results: The distribution of AGC subcategories were as follows: atypical endocervical cells (AEC), 13.4%; atypical endometrial cells, 10.9%; AGC, not otherwise specified, 49.8%; AEC, favor neoplastic, 6.7%; AGC, favor neoplastic, 19.2%. Precancerous lesions and malignancies were diagnosed in 58.9% of cases, with endometrial carcinoma being the most common (24.4%), followed by adenocarcinoma (10.0%). A total of 358 patients underwent hrHPV testing, with a positive rate of 35.2%, hrHPV positivity significantly increased the risk of cervical lesions, while endometrial lesions and pelvic malignancies were more common in hrHPV-negative patients.
Conclusion: This study showed that cytological diagnosis of AGC has high predictive value for cervical lesions, endometrial lesions, and pelvic malignancies. A more detailed triage procedure based on the AGC subcategory can reduce the possibility of missed diagnoses of reproductive tract tumors. The combination of hrHPV detection and age can serve as an important basis for the further diagnosis and management of AGC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/CEJ.0000000000000969 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Expertise in Gynecological Pathology Impacts Diagnosis of Atypical Glandular Cell Category in Cervical Cytology.
J Low Genit Tract Dis
August 2025
Department of Pathology, The University of Chicago, Chicago, IL.
Objectives: The Pap test is effective for detecting squamous neoplasia, but the interpretation of atypical glandular cell (AGC) remains challenging because of its rarity, complex cytologic features, and interobserver variability. Although AGC represents a small proportion of Pap test diagnoses, it often leads to extensive follow-up. This study aimed to assess whether gynecologic pathology expertise improves diagnostic accuracy and reduces unnecessary interventions in AGC interpretation.
View Article and Find Full Text PDFAcidic alterations: impact of glacial acetic acid treatment on interpretations of atypical endocervical and atypical glandular cells, not otherwise specified in Pap tests.
J Am Soc Cytopathol
July 2025
Diagnostics Institute, Cleveland Clinic, Cleveland, Ohio.
Introduction: Glacial acetic acid (GAA) is used in ThinPrep Pap tests to clear excess blood, but it may alter glandular cell appearance, particularly that of endocervical cells, potentially increasing false-positive interpretations. This may be countered by increased awareness of these cytologic alterations.
Materials And Methods: We retrospectively analyzed all cervical and vaginal Pap tests from 2018 to 2022, comparing rates of "Atypical Endocervical Cells" (AEC) and "Atypical Glandular Cells, Not Otherwise Specified" (AGC) interpretations in GAA-treated and untreated Pap tests.
Risk Assessment of Precancers and Cancers in Women with Atypical Glandular Cells of Endocervical, Endometrial, and Unknown Origin.
J Cancer
July 2025
Departments of Pathology, The International Peace Maternal and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, 200030.
To assess the risk of precancers [high-grade squamous intraepithelial lesions (HSIL), adenocarcinoma (AIS) and atypical endometrial hyperplasia (AEH)] and cancers [squamous cell carcinoma (SCC) and adenocarcinoma (ADC)] in women with atypical glandular cells (AGC) cytology. : A total of 1,028 women diagnosed with abnormal cervical glandular cytology from January 2019 and December 2023 were enrolled. Of these, 670 underwent both HPV genotyping and cervical biopsy.
View Article and Find Full Text PDFEvaluation of Diagnostic Parameters of Cytodiagnostics as a screening tool conducted in 2005-2020 as part of the National Population-Based Cervical Cancer Screening Program in Poland.
Ginekol Pol
July 2025
Division of Gynecology, Department of Perinatology and Gynecology, Gynecology and Obstetrics Clinical Hospital, Karol Marcinkowski University of Medical Sciences, Poznan, Poland, Poland.
Objectives: We assessed the diagnostic parameters of cytodiagnosis as a screening method used in the National Population-Based Cervical Cancer Screening Program compared to out-program screening.
Material And Methods: A retrospective analysis of 800 results obtained during routine screening for the National Population-Based Cervical Cancer Screening Program and out-program samples. Abnormal cytologic interpretations, which were an indication for colposcopy as well as HPV DNA HR test and the final histopathology test, both from in- and out-program patients, were statistically analyzed.
The clinical significance of atypical glandular cells in Papanicolaou tests: changes in diagnostic patterns over 15 years at a single institution.
J Am Soc Cytopathol
May 2025
Department of Pathology, University of Pittsburgh, UPMC Magee Womens Hospital, Pittsburgh, Pennsylvania.
Introduction: Detection of atypical glandular cells (AGCs) by Papanicolaou (Pap) test remains a significant challenge in gynecological cytology. We compared follow-up diagnoses, age groups, and human papillomavirus (HPV) results for AGC at our institution to that of our previous study (study period 2008-2013).
Methods: AGC Paps diagnosed and HPV results between January 2020 and June 2024 were obtained from the database at UPMC Magee-Womens Hospital.